deltatrials

Stage iv non-small cell lung cancer Trials in Detroit, United States

Conditions / Stage iv non-small cell lung cancer / Detroit, United States

Stage iv non-small cell lung cancer is a medical condition with active clinical research programs worldwide.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID Title Status Phase
NCT00976677 Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer TERMINATED PHASE2
NCT00986674 Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer COMPLETED PHASE2
NCT00955305 Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer TERMINATED PHASE2
NCT00738881 Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer TERMINATED PHASE3
NCT02134912 S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib TERMINATED PHASE2
NCT03137771 Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer ACTIVE_NOT_RECRUITING PHASE2
NCT02728596 S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) COMPLETED NA
NCT02206334 Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer COMPLETED PHASE1
NCT02438722 S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer ACTIVE_NOT_RECRUITING PHASE2/PHASE3
NCT03087708 Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer TERMINATED PHASE2

Related Pages